No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3f1sA_, 1.0000, 0.00, 1.000, 385, 385, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
2, p3h5cA_, 0.9581, 0.00, 1.000, 385, 385, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
3, d3kcgI_, 0.9285, 1.35, 0.923, 384, 379, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
4, d4ajtA_, 0.9249, 2.15, 0.272, 419, 379, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
5, d2gd4C1, 0.9166, 1.90, 0.751, 372, 370, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
6, d2gd4I1, 0.9160, 2.31, 0.271, 418, 377, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
7, d1sr5A_, 0.9160, 2.32, 0.276, 417, 377, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
8, d1jmoA_, 0.9129, 2.07, 0.270, 409, 374, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
9, d1tb6I_, 0.9121, 1.95, 0.314, 425, 373, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
10, d1e03I_, 0.9114, 1.95, 0.314, 425, 373, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
11, d1ophA_, 0.9110, 2.39, 0.268, 412, 377, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
12, d1azxI_, 0.9109, 2.29, 0.269, 418, 375, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
13, d1hp7A_, 0.9073, 1.75, 0.347, 375, 369, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
14, d5hgcA1, 0.9022, 2.41, 0.271, 417, 376, A SERPIN STRUCTURE
15, p4if8A_, 0.9014, 1.80, 0.331, 376, 369, STRUCTURE OF VASPIN
16, d1ovaD_, 0.9014, 1.80, 0.331, 376, 369, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
17, p4y40A_, 0.9007, 1.88, 0.317, 368, 366, STRUCTURE OF VASPIN MUTANT D305C V383C
18, d2antI_, 0.9007, 1.88, 0.317, 368, 366, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
19, d1ovaA_, 0.8998, 1.73, 0.304, 367, 365, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
20, d1nq9I_, 0.8998, 1.78, 0.247, 385, 365, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
21, d1dzhI_, 0.8991, 1.79, 0.247, 385, 365, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
22, d1e05I_, 0.8986, 1.76, 0.302, 366, 364, PLASMA ALPHA ANTITHROMBIN-III
23, p4y3kA_, 0.8982, 2.60, 0.272, 419, 378, STRUCTURE OF VASPIN MUTANT E379S
24, d1uhgD_, 0.8965, 1.83, 0.247, 383, 365, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
25, d1e04I_, 0.8962, 2.34, 0.270, 406, 371, PLASMA BETA ANTITHROMBIN-III
26, d4dy7C_, 0.8957, 2.64, 0.268, 417, 377, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
27, d3evjI_, 0.8956, 2.60, 0.266, 417, 376, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
28, d1uhgB_, 0.8956, 1.80, 0.305, 367, 364, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
29, d5ncsA1, 0.8950, 1.94, 0.252, 380, 365, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
30, d1oyhI_, 0.8950, 2.62, 0.269, 403, 375, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
31, d5ncsB1, 0.8948, 1.70, 0.279, 377, 362, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
32, p5io1A_, 0.8941, 2.40, 0.267, 404, 371, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
33, d1qlpA_, 0.8939, 1.86, 0.250, 380, 364, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
34, p3druA_, 0.8936, 1.95, 0.246, 370, 362, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
35, d1oo8A_, 0.8936, 1.95, 0.246, 370, 362, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
36, d2hijI1, 0.8934, 2.70, 0.268, 416, 377, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
37, d1antI_, 0.8928, 1.91, 0.246, 370, 362, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
38, p5io1B_, 0.8924, 1.71, 0.334, 365, 362, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
39, d3ne4A_, 0.8919, 1.89, 0.329, 372, 365, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
40, d1ovaB_, 0.8919, 1.61, 0.347, 363, 360, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
41, d4dy7F_, 0.8917, 1.79, 0.344, 370, 363, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
42, p4if8B_, 0.8915, 2.64, 0.267, 411, 375, STRUCTURE OF VASPIN
43, p4y3kB_, 0.8913, 2.55, 0.267, 402, 374, STRUCTURE OF VASPIN MUTANT E379S
44, d1uhgA_, 0.8913, 1.70, 0.335, 364, 361, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
45, d4x30A_, 0.8912, 1.82, 0.331, 370, 363, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
46, p5nbuA_, 0.8911, 1.76, 0.255, 371, 361, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
47, p4y40B_, 0.8910, 1.94, 0.278, 378, 363, STRUCTURE OF VASPIN MUTANT D305C V383C
48, d3cwlA_, 0.8910, 1.94, 0.278, 378, 363, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
49, d2b4xI1, 0.8903, 1.63, 0.302, 361, 358, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
50, d1athA_, 0.8903, 1.74, 0.301, 361, 359, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
51, p3druB_, 0.8899, 1.94, 0.253, 378, 363, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
52, d2behI_, 0.8899, 1.89, 0.320, 372, 363, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
53, d1t1fC_, 0.8894, 1.89, 0.320, 372, 363, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
54, d1t1fB_, 0.8894, 1.91, 0.341, 370, 364, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
55, d1t1fA_, 0.8894, 1.78, 0.298, 361, 359, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
56, p4ga7A_, 0.8893, 1.91, 0.330, 371, 364, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
57, d1dzgI_, 0.8892, 2.63, 0.267, 413, 374, N135Q-S380C-ANTITHROMBIN-III
58, d1psiA_, 0.8888, 2.42, 0.276, 389, 370, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
59, p5nbvA_, 0.8887, 1.72, 0.344, 362, 360, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
60, d1jmjB_, 0.8883, 2.68, 0.269, 413, 375, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
61, d3cwmA_, 0.8880, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
62, d1jmjA_, 0.8876, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
63, d2qugA_, 0.8870, 2.52, 0.270, 419, 370, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
64, d1sekA_, 0.8863, 1.66, 0.292, 369, 356, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
65, p3druC_, 0.8859, 2.71, 0.263, 422, 377, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
66, d2zv6B1, 0.8854, 1.94, 0.330, 371, 364, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
67, p4ga7B_, 0.8846, 1.88, 0.344, 369, 363, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
68, d4dy0B_, 0.8845, 2.12, 0.314, 387, 366, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
69, d1ovaC_, 0.8842, 1.87, 0.331, 369, 362, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
70, d3drmA_, 0.8830, 2.12, 0.314, 397, 366, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
71, p1yxaA_, 0.8823, 1.83, 0.330, 368, 361, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
72, d1jvqI_, 0.8821, 2.24, 0.247, 376, 365, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
73, d1i99I_, 0.8816, 1.62, 0.350, 360, 357,  
74, d1k9oI_, 0.8813, 2.10, 0.269, 370, 360, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
75, d1uhgC_, 0.8812, 1.55, 0.288, 367, 354, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
76, d1r1lI_, 0.8812, 1.81, 0.284, 370, 359, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
77, d1lk6I_, 0.8805, 1.63, 0.250, 373, 356, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
78, d5du3A_, 0.8802, 1.80, 0.331, 362, 359, ACTIVE FORM OF HUMAN C1-INHIBITOR
79, p3f5nA_, 0.8802, 1.86, 0.320, 372, 356, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
80, p3fgqA_, 0.8799, 1.86, 0.320, 372, 356, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
81, p3fgqB_, 0.8798, 2.86, 0.265, 410, 378, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
82, p1yxaB_, 0.8791, 2.15, 0.267, 376, 363, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
83, d5du3B_, 0.8790, 2.15, 0.267, 376, 363, ACTIVE FORM OF HUMAN C1-INHIBITOR
84, d2b5tI_, 0.8789, 2.15, 0.267, 376, 363, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
85, d1br8I_, 0.8784, 1.70, 0.256, 370, 356, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
86, d1imvA_, 0.8780, 2.86, 0.270, 416, 378, 2.85 A CRYSTAL STRUCTURE OF PEDF
87, p3f5nD_, 0.8778, 2.87, 0.270, 410, 378, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
88, p2ol2A_, 0.8775, 2.29, 0.244, 378, 365, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
89, p2hi9A_, 0.8764, 2.29, 0.244, 378, 365, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
90, p2hi9B_, 0.8763, 2.07, 0.270, 364, 359, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
91, d2ceoA_, 0.8762, 2.02, 0.273, 374, 362, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
92, d2ceoB_, 0.8754, 2.02, 0.273, 374, 362, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
93, p5ce0B_, 0.8749, 2.02, 0.273, 374, 362, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
94, d1kctA_, 0.8748, 1.79, 0.327, 368, 355, ALPHA1-ANTITRYPSIN
95, d3le2A1, 0.8743, 2.43, 0.243, 377, 366, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
96, p5cdxA_, 0.8741, 2.82, 0.261, 415, 372, CRYSTAL STRUCTURE OF CONSERPIN
97, d3r4lA_, 0.8722, 2.80, 0.255, 404, 377, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
98, d4dteA_, 0.8715, 2.07, 0.260, 375, 361, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
99, p3f5nB_, 0.8708, 2.07, 0.260, 375, 361, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
100, d1xqgB1, 0.8707, 1.82, 0.275, 363, 356, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
101, d1attB_, 0.8700, 1.94, 0.332, 360, 355, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
102, d1attA_, 0.8699, 1.94, 0.332, 360, 355, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
103, d3pb1I_, 0.8692, 1.92, 0.334, 356, 353, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
104, d3ozqA1, 0.8692, 1.77, 0.332, 354, 352, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
105, d1xqgA1, 0.8689, 1.91, 0.329, 367, 356, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
106, p5ce0A_, 0.8686, 1.95, 0.329, 367, 356, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
107, d4dy0A_, 0.8668, 1.62, 0.390, 353, 351, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
108, d1xqjA1, 0.8664, 2.49, 0.341, 375, 369, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
109, p2r9yA_, 0.8658, 2.41, 0.247, 391, 364, STRUCTURE OF ANTIPLASMIN
110, d2peeB_, 0.8646, 2.41, 0.247, 391, 364, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
111, d1db2A_, 0.8642, 1.63, 0.402, 353, 351, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
112, d5duqB_, 0.8639, 2.40, 0.275, 377, 364, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
113, d1xu8B1, 0.8635, 2.21, 0.256, 374, 363, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
114, d2peeA_, 0.8628, 2.21, 0.256, 374, 363, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
115, p3zhaD_, 0.8621, 1.81, 0.278, 366, 353, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
116, d2h4rA1, 0.8619, 2.14, 0.225, 375, 360, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
117, d4dteB_, 0.8613, 2.66, 0.270, 410, 370, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
118, d4eb1I_, 0.8612, 2.63, 0.266, 420, 368, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
119, p3b9fI_, 0.8608, 2.17, 0.274, 375, 361, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
120, d1by7A_, 0.8608, 1.97, 0.258, 361, 353, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
121, d5duqA_, 0.8593, 1.97, 0.258, 361, 353, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
122, d2zv6A_, 0.8589, 2.17, 0.225, 375, 360, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
123, p3vvjC_, 0.8584, 2.17, 0.225, 375, 360, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
124, d2zv6C1, 0.8579, 1.65, 0.395, 352, 349, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
125, d1atuA_, 0.8579, 1.77, 0.285, 362, 351, UNCLEAVED ALPHA-1-ANTITRYPSIN
126, d1xu8A1, 0.8574, 2.21, 0.225, 375, 360, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
127, p3vvjB_, 0.8561, 1.98, 0.285, 365, 355, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
128, p3vvjA_, 0.8559, 1.98, 0.285, 365, 355, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
129, d1r1lL_, 0.8557, 2.66, 0.225, 387, 364, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
130, p3zhaA_, 0.8549, 2.35, 0.277, 377, 361, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
131, d1e04L_, 0.8549, 2.12, 0.264, 365, 356, PLASMA BETA ANTITHROMBIN-III
132, d3pzfA_, 0.8548, 2.23, 0.230, 372, 357, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
133, p2hi9C_, 0.8548, 2.38, 0.225, 387, 360, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
134, d1e05L_, 0.8548, 2.38, 0.225, 387, 360, PLASMA ALPHA ANTITHROMBIN-III
135, p3zhaC_, 0.8546, 2.47, 0.227, 368, 365, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
136, p2ol2B_, 0.8544, 1.97, 0.293, 368, 352, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
137, d1dvmA_, 0.8544, 1.97, 0.293, 368, 352, ACTIVE FORM OF HUMAN PAI-1
138, p6cj7A_, 0.8542, 2.07, 0.268, 364, 355, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
139, d1br8L_, 0.8542, 3.15, 0.261, 411, 372, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
140, d1dzgL_, 0.8540, 2.10, 0.334, 356, 350, N135Q-S380C-ANTITHROMBIN-III
141, d1dvmD_, 0.8536, 1.39, 0.289, 354, 343, ACTIVE FORM OF HUMAN PAI-1
142, p3zhaB_, 0.8535, 1.96, 0.256, 362, 352, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
143, d1dvmC_, 0.8523, 1.47, 0.271, 350, 343, ACTIVE FORM OF HUMAN PAI-1
144, d2antL_, 0.8521, 2.19, 0.256, 384, 356, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
145, d1dvmB_, 0.8520, 1.42, 0.272, 349, 342, ACTIVE FORM OF HUMAN PAI-1
146, d2b4xL_, 0.8518, 2.67, 0.339, 374, 369, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
147, d4roaA_, 0.8515, 1.91, 0.234, 364, 351, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
148, d2hijL_, 0.8515, 2.20, 0.253, 384, 356, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
149, d2behL_, 0.8506, 2.22, 0.253, 384, 356, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
150, d1dzhL_, 0.8502, 2.53, 0.274, 409, 361, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
151, d1oyhL_, 0.8501, 2.76, 0.228, 380, 368, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
152, d1wz9B_, 0.8500, 2.76, 0.228, 380, 368, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
153, d3q03B_, 0.8499, 2.59, 0.266, 412, 361, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
154, p4au4G_, 0.8496, 2.19, 0.244, 369, 353, CRYSTAL STRUCTURE OF HSP47
155, p4au4C_, 0.8495, 2.19, 0.244, 369, 353, CRYSTAL STRUCTURE OF HSP47
156, d1lk6L_, 0.8495, 1.66, 0.332, 346, 343, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
157, d4g8oC1, 0.8494, 2.59, 0.271, 417, 362, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
158, d1db2B_, 0.8494, 2.54, 0.227, 376, 365, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
159, d5brrI_, 0.8491, 1.47, 0.337, 343, 341, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
160, d4g8oD1, 0.8491, 2.36, 0.275, 375, 356, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
161, p4au4F_, 0.8490, 1.92, 0.263, 357, 350, CRYSTAL STRUCTURE OF HSP47
162, p3zhaL_, 0.8490, 2.55, 0.275, 398, 360, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
163, d3q03A_, 0.8489, 2.59, 0.266, 409, 361, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
164, d3q02B_, 0.8489, 2.37, 0.275, 372, 356, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
165, d1jvqL_, 0.8489, 2.45, 0.230, 364, 361, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
166, d4g8rB1, 0.8488, 2.18, 0.277, 364, 354, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
167, p2dutD_, 0.8483, 2.58, 0.275, 398, 360, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
168, p2dutC_, 0.8483, 2.17, 0.280, 365, 353, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
169, p2dutB_, 0.8483, 2.61, 0.271, 410, 361, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
170, p2dutA_, 0.8483, 2.24, 0.244, 364, 352, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
171, d1jtiA_, 0.8482, 2.61, 0.267, 409, 360, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
172, d4ic0C_, 0.8481, 2.57, 0.279, 403, 359, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
173, d4rsqK_, 0.8479, 2.62, 0.269, 407, 360, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
174, d2vdxA_, 0.8479, 2.66, 0.263, 410, 361, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
175, d1jtiB_, 0.8479, 2.07, 0.232, 355, 349, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
176, d4ic0A_, 0.8478, 2.27, 0.277, 364, 354, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
177, p3zhaP_, 0.8475, 2.60, 0.237, 368, 363, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
178, d1b3kC_, 0.8471, 2.63, 0.227, 370, 365, PLASMINOGEN ACTIVATOR INHIBITOR-1
179, d2ach.1, 0.8470, 2.58, 0.267, 406, 359, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
180, d1b3kA_, 0.8470, 2.17, 0.276, 366, 352, PLASMINOGEN ACTIVATOR INHIBITOR-1
181, d4robB_, 0.8468, 2.21, 0.281, 362, 352, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
182, p3zhaQ_, 0.8467, 2.50, 0.268, 372, 358, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
183, d3ut3C_, 0.8467, 2.31, 0.272, 366, 353, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
184, d4ro9A_, 0.8465, 2.59, 0.234, 368, 363, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
185, d3ut3D_, 0.8462, 2.63, 0.231, 369, 364, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
186, d1d5s.1, 0.8462, 2.08, 0.280, 360, 350, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
187, d1as4.1, 0.8461, 2.21, 0.276, 362, 352, CLEAVED ANTICHYMOTRYPSIN A349R
188, d3ut3B_, 0.8459, 2.59, 0.270, 406, 359, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
189, d4rsqL_, 0.8457, 2.18, 0.276, 367, 352, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
190, d4ic0D_, 0.8457, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
191, d4eb1L_, 0.8456, 2.19, 0.293, 366, 351, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
192, p4au4D_, 0.8456, 2.19, 0.293, 366, 351, CRYSTAL STRUCTURE OF HSP47
193, d4rsqE_, 0.8455, 2.19, 0.293, 366, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
194, d4rsqG_, 0.8454, 2.09, 0.254, 381, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
195, d3ut3A_, 0.8453, 2.19, 0.273, 366, 352, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
196, d8api.1, 0.8449, 2.16, 0.244, 356, 348, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
197, p3zhaK_, 0.8446, 2.11, 0.299, 366, 351, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
198, d4rsqH_, 0.8445, 2.09, 0.254, 381, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
199, d4c41A_, 0.8445, 2.20, 0.273, 366, 352, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
200, d4rsqB_, 0.8442, 2.75, 0.227, 373, 366, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
201, p3f5nC_, 0.8442, 2.40, 0.277, 373, 354, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
202, d3q02A_, 0.8441, 2.30, 0.324, 372, 355, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
203, d4rsqF_, 0.8440, 2.40, 0.277, 373, 354, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
204, d1azxL_, 0.8435, 2.15, 0.244, 356, 348, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
205, d1e03L_, 0.8434, 2.55, 0.229, 365, 362, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
206, d9api.1, 0.8433, 2.41, 0.277, 368, 354, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
207, d4ic0B_, 0.8433, 2.09, 0.254, 353, 347, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
208, d4rsqA_, 0.8431, 2.12, 0.280, 360, 350, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
209, d3ndaA_, 0.8428, 2.63, 0.331, 375, 363, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
210, d1antL_, 0.8428, 2.21, 0.324, 369, 352, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
211, p4au4B_, 0.8427, 2.12, 0.280, 360, 350, CRYSTAL STRUCTURE OF HSP47
212, d4c49A_, 0.8426, 2.21, 0.244, 356, 348, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
213, d7api.1, 0.8423, 2.08, 0.278, 359, 349, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
214, d4g8oB1, 0.8423, 2.49, 0.272, 392, 356, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
215, p5c98B_, 0.8422, 2.59, 0.235, 366, 361, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
216, d4robA_, 0.8420, 2.21, 0.244, 356, 348, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
217, p4au4A_, 0.8420, 2.28, 0.244, 357, 349, CRYSTAL STRUCTURE OF HSP47
218, d4g8oA1, 0.8414, 2.27, 0.278, 367, 352, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
219, p4au4E_, 0.8408, 2.59, 0.335, 376, 361, CRYSTAL STRUCTURE OF HSP47
220, d1nq9L_, 0.8408, 2.89, 0.228, 374, 368, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
221, p5ei0A_, 0.8407, 2.35, 0.244, 357, 349, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
222, d1oc0A_, 0.8407, 2.23, 0.290, 367, 352, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
223, d1b3kB_, 0.8407, 2.23, 0.290, 367, 352, PLASMINOGEN ACTIVATOR INHIBITOR-1
224, d3evjL_, 0.8406, 2.22, 0.245, 355, 347, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
225, d2vdyB_, 0.8406, 2.21, 0.256, 358, 347, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
226, d1b3kD_, 0.8406, 2.03, 0.279, 358, 348, PLASMINOGEN ACTIVATOR INHIBITOR-1
227, d4rsqJ_, 0.8402, 2.11, 0.249, 353, 346, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
228, d4p0oA_, 0.8402, 2.84, 0.271, 414, 361, CLEAVED SERPIN 42DA
229, p4au2A_, 0.8402, 2.84, 0.274, 423, 361, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
230, d2vdxB_, 0.8397, 2.84, 0.274, 423, 361, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
231, d4ro9B_, 0.8396, 2.57, 0.336, 375, 360, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
232, d4rsqI_, 0.8395, 2.08, 0.279, 358, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
233, d4rsqD_, 0.8395, 2.24, 0.245, 356, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
234, d3caa.1, 0.8395, 2.53, 0.305, 374, 357, CLEAVED ANTICHYMOTRYPSIN A347R
235, d4c49C_, 0.8392, 2.53, 0.305, 374, 357, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
236, d4c49B_, 0.8392, 2.60, 0.272, 392, 357, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
237, d4robC_, 0.8382, 2.66, 0.234, 368, 363, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
238, d4g8rA_, 0.8382, 2.16, 0.291, 367, 351, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
239, d4rsqC_, 0.8369, 2.59, 0.336, 375, 360, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
240, p5ei0E_, 0.8368, 2.10, 0.279, 358, 348, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
241, p3f5nE_, 0.8358, 2.53, 0.165, 364, 357, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
242, d2vdyA_, 0.8356, 2.53, 0.165, 364, 357, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
243, p4au2D_, 0.8352, 2.21, 0.245, 356, 347, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
244, d1wz9A_, 0.8345, 2.62, 0.233, 366, 361, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
245, p5c98A_, 0.8341, 2.11, 0.276, 358, 348, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
246, d4zk0A_, 0.8332, 2.67, 0.229, 367, 362, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
247, d1ezx.1, 0.8331, 2.76, 0.267, 413, 359, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
248, d3ndaB_, 0.8329, 2.39, 0.305, 372, 357, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
249, d4caa.1, 0.8328, 2.39, 0.305, 372, 357, CLEAVED ANTICHYMOTRYPSIN T345R
250, p4au3D_, 0.8325, 2.29, 0.283, 364, 350, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
251, d1a7cA_, 0.8324, 2.13, 0.279, 358, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
252, d1hle.1, 0.8308, 2.72, 0.265, 417, 359, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
253, d1qmb.1, 0.8302, 2.03, 0.301, 361, 346, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
254, d4zk3A_, 0.8300, 2.13, 0.279, 358, 348, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
255, p4au2B_, 0.8299, 2.21, 0.246, 355, 346, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
256, p2wy0C_, 0.8294, 2.42, 0.277, 371, 354, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
257, d2arqA_, 0.8278, 2.42, 0.277, 371, 354, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
258, p2wxyC_, 0.8270, 2.66, 0.232, 367, 362, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
259, d2arrA_, 0.8267, 2.05, 0.301, 360, 346, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
260, d3cvmA_, 0.8253, 1.94, 0.251, 348, 342, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
261, d3cvmB_, 0.8236, 2.32, 0.245, 356, 347, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
262, p5m3yA_, 0.8218, 2.34, 0.244, 355, 348, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
263, p4r9iA_, 0.8215, 2.20, 0.327, 366, 349, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
264, p2wxzA_, 0.8214, 2.08, 0.296, 363, 348, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
265, d1jrrA_, 0.8208, 2.16, 0.293, 362, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
266, p4au3C_, 0.8206, 2.14, 0.244, 351, 344, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
267, d4c49D_, 0.8203, 2.13, 0.280, 357, 347, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
268, p2x0bH_, 0.8202, 2.17, 0.247, 354, 344, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
269, p2x0bF_, 0.8202, 2.38, 0.307, 371, 355, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
270, p2x0bB_, 0.8202, 1.57, 0.268, 340, 336, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
271, p2x0bD_, 0.8196, 2.11, 0.298, 361, 346, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
272, d3eoxA_, 0.8181, 2.46, 0.229, 359, 354, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
273, d4p0fA_, 0.8178, 2.11, 0.232, 357, 345, CLEAVED SERPIN 42DA (C 2 2 21)
274, p2wxwA_, 0.8173, 2.38, 0.169, 359, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
275, d4ro9C_, 0.8163, 2.18, 0.270, 367, 348, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
276, p4au3A_, 0.8162, 2.60, 0.340, 371, 356, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
277, p4au3B_, 0.8158, 2.43, 0.302, 372, 354, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
278, p2wxxC_, 0.8158, 2.30, 0.321, 366, 349, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
279, d1sngA1, 0.8145, 2.53, 0.220, 359, 355, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
280, d1lq8.4, 0.8143, 2.48, 0.282, 364, 354, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
281, p2wxxD_, 0.8132, 2.21, 0.296, 375, 348, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
282, d3dlwA_, 0.8127, 2.21, 0.296, 375, 348, ANTICHYMOTRYPSIN
283, d1lq8.1, 0.8125, 2.59, 0.331, 368, 356, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
284, p2wxxB_, 0.8122, 2.19, 0.268, 366, 347, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
285, p2wxxA_, 0.8122, 2.38, 0.234, 354, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
286, d1lq8.2, 0.8098, 3.02, 0.210, 424, 362, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
287, d1qmnA_, 0.8084, 2.38, 0.280, 360, 350, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
288, p2wy1B_, 0.8050, 2.38, 0.280, 360, 350, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
289, p2wy1A_, 0.8050, 3.01, 0.211, 419, 361, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
290, d3stoA_, 0.8049, 2.42, 0.280, 358, 350, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
291, p2wxzC_, 0.8048, 2.56, 0.278, 377, 352, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
292, d1lq8.3, 0.8041, 2.58, 0.278, 377, 352, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
293, d2v95A_, 0.8039, 3.11, 0.208, 418, 361, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
294, p5cdzA_, 0.8038, 3.03, 0.137, 378, 358, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
295, d2v6dA_, 0.8038, 3.03, 0.137, 378, 358,  
296, d2pefA_, 0.8009, 3.47, 0.218, 422, 371, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
297, d4aqhA1, 0.8004, 2.44, 0.284, 357, 348, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
298, d1athB_, 0.7983, 2.75, 0.216, 357, 356, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
299, p4au2C_, 0.7973, 2.12, 0.296, 356, 341, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
300, d4aqhB1, 0.7966, 3.06, 0.211, 409, 361, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
301, d4aqhC1, 0.7958, 3.06, 0.211, 409, 361, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
302, p4ajuA_, 0.7940, 3.06, 0.211, 409, 361, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
303, d1iz2A_, 0.7918, 2.99, 0.211, 408, 360, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
304, d1c5gA_, 0.7908, 2.64, 0.283, 370, 350, PLASMINOGEN ACTIVATOR INHIBITOR-1
305, d3lw2A_, 0.7887, 2.40, 0.275, 369, 345, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
306, d2oayA1, 0.7869, 3.25, 0.209, 438, 363, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
307, d1mtp.1, 0.7852, 3.25, 0.209, 438, 363, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
308, p5m3xB_, 0.7847, 1.85, 0.251, 336, 331, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
309, d1dvnA_, 0.7832, 2.69, 0.221, 354, 353, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
310, d4kdsA_, 0.7826, 2.56, 0.226, 351, 349, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
311, p5m3xA_, 0.7817, 3.16, 0.211, 422, 361, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
312, d2vh4A_, 0.7813, 2.19, 0.257, 345, 335, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
313, d1lj5A_, 0.7809, 2.34, 0.333, 359, 342, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
314, p2xn5A_, 0.7793, 3.14, 0.211, 411, 360, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
315, p2rivA_, 0.7772, 2.59, 0.309, 360, 343, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
316, p2xn7A_, 0.7762, 2.34, 0.333, 358, 342, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
317, p4yiaA_, 0.7750, 3.21, 0.213, 428, 362, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
318, p2riwA_, 0.7737, 3.17, 0.208, 412, 361, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
319, p2xn6A_, 0.7726, 2.33, 0.334, 357, 341, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
320, p2xn3A_, 0.7724, 2.85, 0.316, 365, 345, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
321, d2vh4B_, 0.7721, 3.35, 0.224, 417, 362, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
322, p5ncwA_, 0.7634, 3.35, 0.224, 418, 362, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
323, p3nddA_, 0.7596, 2.79, 0.212, 361, 344, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
324, p3ndfA_, 0.7577, 2.79, 0.212, 361, 344, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
325, d1c8o.1, 0.7559, 3.43, 0.221, 413, 362, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
326, d2d26A1, 0.7549, 2.38, 0.332, 357, 340, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
327, d2znhA_, 0.7539, 2.40, 0.253, 342, 340, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
328, p3t1pA_, 0.7484, 2.45, 0.401, 361, 339, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
329, d2znhB_, 0.7480, 2.40, 0.253, 342, 340, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
330, p5ncuA_, 0.7477, 2.69, 0.233, 366, 344, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
331, d9paiA_, 0.7451, 2.85, 0.277, 379, 347, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
332, p3dy0A_, 0.7412, 2.18, 0.282, 362, 333, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
333, p5nctA_, 0.7401, 2.28, 0.228, 338, 334, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
334, d1f0c.1, 0.7277, 2.90, 0.280, 379, 347, STRUCTURE OF THE VIRAL SERPIN CRMA
335, d1m93.1, 0.7174, 2.91, 0.277, 379, 347, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
336, d1jjo.2, 0.7057, 2.28, 0.973, 338, 329, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
337, d1jjo.1, 0.7057, 2.93, 0.342, 371, 348, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
338, p4pywA1, 0.6813, 3.06, 0.284, 379, 348, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
339, p4bb2A1, 0.6001, 3.06, 0.284, 379, 348, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
340, p4afxA1, 0.5994, 2.48, 0.281, 365, 334, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
341, p2h4qA1, 0.5705, 2.74, 0.251, 366, 338, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
342, p5om7A1, 0.5627, 2.53, 0.254, 355, 334, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
343, p5om2A1, 0.5618, 2.53, 0.254, 355, 334, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
344, p2h4pA1, 0.5606, 3.04, 0.213, 387, 347, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
345, p5om5A1, 0.5588, 3.07, 0.283, 379, 346, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
346, p5om6A1, 0.5571, 2.81, 0.275, 370, 338, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
347, p5om8A1, 0.5567, 3.02, 0.217, 383, 345, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
348, p5om3A1, 0.5563, 3.01, 0.236, 380, 343, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
349, p6ftpA1, 0.5406, 3.22, 0.282, 379, 347, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
350, p5om6C1, 0.5372, 2.30, 0.307, 341, 326, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
351, p3f02B1, 0.5219, 2.38, 0.305, 339, 325, CLEAVED HUMAN NEUROSERPIN
352, p3f02A1, 0.5100, 2.28, 0.306, 339, 324, CLEAVED HUMAN NEUROSERPIN
